首页> 外文OA文献 >Barrett’s Oesophagus - studies of novel opticaluddiagnostic tools and minimally invasive therapies
【2h】

Barrett’s Oesophagus - studies of novel opticaluddiagnostic tools and minimally invasive therapies

机译:巴雷特的食管-新型光学 ud的研究诊断工具和微创疗法

摘要

Dysplasia arising in Barrett’s oesophagus (BO) confers risk of progression toudoesophageal adenocarcinoma (OAC), but it is variable and confounded by sampling errorudand diagnostic inter-observer variability. There is a need for biomarkers to accuratelyuddefine risk and guide surveillance and treatment strategies. Oesophagectomy is theudpreferred treatment of high grade dysplasia (HGD), although this has been challenged byudthe emergence of endoscopic therapy.udThis thesis has shown image cytometric DNA ploidy analysis (ICDA) is accurate whenudcompared to flow cytometry. In a multi centre biomarker validation study, ICDAudpredicted cancer risk in non dysplastic BO. ICDA also predicted relapse followingudphotodynamic therapy (PDT).udNucleotyping (NT) is an imaging technique that evaluates textural changes of nuclei,udwhich correlate with chromatin content and organisation. In this thesis NT wasuddemonstrated to yield additional diagnostic information over ICDA alone, and theudcombination was highly accurate for dysplasia classification.udIn an experiment evaluating replication licensing factors in OAC, those representing theudS-G2-M phases of the cell cycle correlated with aneuploidy. Polo like kinase 1udupregulation had the strongest correlation, the first time this has been shown in BO.udElastic scattering spectroscopy detected DNA ploidy abnormalities with equal accuracyudusing a standard or near infra-red enhanced spectrometer. In a prospective in vivoudsurveillance study, fewer biopsies were taken without a change in the diagnostic yield foruddysplasia. A field carcinogenesis effect was also demonstrated, independent of bothuddysplasia and DNA ploidy abnormalities.udFinally, in a randomised control trial of PDT for HGD, patients with BO less than 7cmudhad significantly higher efficacy and better tolerability with ALA than photofrin.udRadiofrequency ablation was shown to be a safe and effective rescue therapy for patientsudthat failed PDT.udIn summary these studies advance our understanding of biomedical optics for the riskudstratification and treatment of Barrett’s oesophagus.
机译:Barrett食道(BO)发生异型增生具有发展为食道腺癌(OAC)的风险,但它是可变的,并因抽样误差 udc和观察者之间的诊断差异而混淆。需要生物标志物准确/定义风险并指导监测和治疗策略。食管切除术是高度不典型增生(HGD)的首选治疗方法,尽管这受到内镜治疗方法的挑战。本论文表明,与流式细胞术相比,图像细胞DNA倍性分析(ICDA)是准确的。在一项多中心生物标志物验证研究中,ICDA预测非增生性BO中的癌症风险。 ICDA还预测了 ud光动力疗法(PDT)后的复发。 ud核型分析(NT)是一种评估核质构变化的成像技术,其与染色质含量和组织相关。在本论文中,NT被证明仅通过ICDA即可获得更多的诊断信息,并且udcombination对发育异常的分类非常准确。 ud在评估OAC中复制许可因子的实验中,代表CAD的udS-G2-M阶段。细胞周期与非整倍性有关。 Polo样激酶1 上调具有最强的相关性,这在BO中首次显示。 ud弹性散射光谱法使用标准或近红外增强光谱仪以相同的准确度检测到DNA倍性异常。在一项前瞻性体内/监护研究中,较少的活检没有改变增生的诊断率。最后,在PDT的HGD随机对照试验中,BOD小于7cm的患者对ALD的疗效和耐受性均明显优于光敏蛋白。 ud射频消融已被证明是对PDT失败的患者的一种安全有效的抢救疗法。 ud总而言之,这些研究提高了我们对生物医学光学对Barrett食管的风险未分化和治疗的理解。

著录项

  • 作者

    Dunn J.M.;

  • 作者单位
  • 年度 2011
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号